Twist Bioscience Corporation (TWST)
NASDAQ: TWST · Real-Time Price · USD
31.07
+0.14 (0.45%)
At close: Dec 15, 2025, 4:00 PM EST
31.07
0.00 (0.00%)
After-hours: Dec 15, 2025, 5:12 PM EST
Twist Bioscience Employees
Twist Bioscience had 979 employees as of September 30, 2025. The number of employees increased by 56 or 6.07% compared to the previous year.
Employees
979
Change (1Y)
56
Growth (1Y)
6.07%
Revenue / Employee
$384,650
Profits / Employee
-$79,336
Market Cap
1.90B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Sep 30, 2025 | 979 | 56 | 6.07% |
| Sep 30, 2024 | 923 | 4 | 0.44% |
| Sep 30, 2023 | 919 | -70 | -7.08% |
| Sep 30, 2022 | 989 | 337 | 51.69% |
| Sep 30, 2021 | 652 | 127 | 24.19% |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
TWST News
- 3 days ago - Halper Sadeh LLC Encourages Twist Bioscience Corporation Shareholders to Contact the Firm to Discuss Their Rights - Business Wire
- 11 days ago - Twist Bioscience Launches New Plasmid Preps to Enable Nucleic Acid Therapeutics Research - Business Wire
- 27 days ago - Twist Bioscience Is Bent, Not Broken: Near-Term Strain, Long-Term Strength - Seeking Alpha
- 4 weeks ago - Can Twist Bioscience Drop More? - Forbes
- 4 weeks ago - Twist Bioscience Corporation (TWST) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Twist Bioscience Eyes Profit Turnaround In 2026 After Narrowing Losses - Benzinga
- 4 weeks ago - Twist Bioscience Announces Fiscal 2025 Fourth Quarter and Full Year Financial Results - Business Wire
- 4 weeks ago - Top Wall Street Forecasters Revamp Twist Bioscience Expectations Ahead Of Q4 Earnings - Benzinga